Pharmafile Logo
Pharmafocus logo
Advanced Search

biotech

Showing 15 posts of 861 posts found.

shutterstock_359806121

DNA damage response biotech launches with £25m funding

September 22, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, dna damage response, funding

Cambridge-based Artios Pharma has officially launched after raising £25 million in series A financing from US and European life science …

News

13 deaths in Aurinia’s lupus drug trial despite hitting Phase II target

August 16, 2016
Manufacturing and Production, Research and Development Aurinia, Phase II, biotech, patient deaths, voclosporin

Canadian biotech Aurinia Pharmaceuticals has announced the topline Phase IIb trial results of its lupus nephritis (LN) treatment voclosporin, which …

News
allergan

Allergan set to acquire eye-care biotech ForSight VISION5

August 12, 2016
Medical Communications, Sales and Marketing Allergan, ForSight VISION5, acquisition, biotech, eye care

Allergan has announced its acquisition of privately-held, clinical-stage eye-care biotech ForSight VISION5 for a $95 million upfront payment and a …

News
amgen_flag

Amgen’s denosumab may help check breast cancer in women with BRCA1 gene – Study

June 21, 2016
Manufacturing and Production, Research and Development Amgen, Prolia, Xgeva, biotech, breast cancer, drug trial, genetics

US biotech firm Amgen’s (Nasdaq: AMGN) Prolia (denosumab) to treat osteoporosis and Xgeva to prevent fractures in cancer patients, may …

News
flag_-_union_flag

UK biotech in great shape, according to new industry report

June 16, 2016
Research and Development Europe, UK, biotech, uk bioindustry association

The UK biotechnology sector is going from strength to strength, having raised an “unprecedented” £900 million on the London Stock …

News

US biotech company to try resurrect the clinically dead

May 4, 2016
Research and Development US, bioquark, biotech, brain, central nervous system, clinically dead, dead, patients, ressurect

A US biotech firm has announced plans for a Phase I trial that will see them attempt to bring brain-dead …

News
biogen_logo

Biogen Q1 profits rise boosted by Tecfidera sales

April 22, 2016
Medical Communications, Sales and Marketing Biogen, Q1, biotech, earnings, results, tecfidera

Shares in Biogen (Nasdaq: BIIB) climbed to close up over 5% Thursday after the company reported 18% rise in first-quarter …

News
asthma_inhalers

Vectura agree £441m merger with Skyepharma

March 16, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Skyepharma, UK, biotech, merger, vectura

Vectura (LON: VEC) and Skyepharma (LON: SKP), two UK-based pharma companies, have joined together in a deal worth £441m. The …

News
Novartis window

Novartis forms Mereo as UK biotech spin-off

July 29, 2015
Research and Development Mereo, Novartis, biotech, rare diseases

Novartis has formed a new UK biotech company by selling three investigational drugs in exchange for shares in the new …

News

Horizon forms new cancer advisory board

November 12, 2014
Research and Development, Sales and Marketing Cambridge, Horizon Discovery, Karin Schmitt, Paul Morrill, biotech, sab

UK biotech Horizon Discovery has formed a new Scientific Advisory Board (SAB) for its diagnostics arm to recommend better cancer …

News
Lilly image

Lilly signs Immunocore deal

July 17, 2014
Research and Development, Sales and Marketing Cancer, Oxford, biotech, immunocore, lilly

Eli Lilly has signed a deal with one of the UK’s most high-profile biotech firms to research and potentially develop …

News

Biotech industry failed by UK, says UCB

February 27, 2014
Research and Development, Sales and Marketing Cimzia, NHS, UCB, biotech, doliveux, tellier, vimpat

The UK biotechnology industry has ‘missed the boat’ and not fulfilled its potential, according to outgoing UCB chief executive Roch …

News
Amgen image

Amgen commits $2.5 million to biotech educational grants

November 12, 2013
Research and Development, Sales and Marketing Amgen, EDC, Onyx, biotech, stem

The Amgen Foundation has announced $2.5 million in new grants for its science programme to aid schools in the US …

News

£10 million boost for synthetic biology

November 6, 2013
Research and Development, Sales and Marketing Biological, Synthetic, biotech

The Biotechnology and Biological Science Research Council (BBSRC) has put up £10 million which can be accessed by small companies …

News
Steven Bates image

New drug pricing plans will ‘damage UK biotech’

August 16, 2013
Research and Development, Sales and Marketing BIA, Hunt, NHS, VBP, bates, biotech

The BioIndustry Association is warning that the government’s new drug pricing scheme could put future investment in the UK’s biotech …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025